SUMMARY Twenty four patients with malignant bile duct obstruction were treated with intraluminal radiotherapy using iridium-192 wire inserted through an endoscopically placed nasobiliary catheter. Biliary drainage after treatment was maintained by an endoprosthesis. The median dose of intraluminal radiotherapy was 6000 cGy; two patients with cholangiocarcinoma were given a second course because of disease extension; four patients with pancreatic carcinoma received additional external irradiation (3000 cGy). There was one early death from a cerebrovascular accident (30 day mortality, 4-2%). Cholangitis (30%) was the major early complication and stent blockage (40%) the major late complication; there were no complications directly attributable to radiotherapy. The median survival for patients with pancreatic carcinoma was 250 days and for cholangiocarcinoma, 300 days. This method is technically feasible and may prove safer than the transhepatic technique. The ability of intraluminal irradiation to improve palliation or lengthen survival in patients with malignant bile duct obstruction remains uncertain. Assessment by a prospective, controlled trial is essential.
Intracavitary irradiation is an accepted form of palliation in patients with oesophageal, gastric and rectal malignancy. ' 2 A high dose of irradiation can be delivered to a limited volume of tissue over a short period -a significant advantage over conventional external radiotherapy. Intraluminal irradiation using iridium or radium placed transhepatically has been used to treat patients with malignant bile duct obstruction.' It has been suggested that this form of treatment, together with catheter or endoprosthetic drainage for the relief of jaundice, may double the survival time in patients with hilar cholangiocarcinoma. 9 Biliary decompression by the transhepatic route has a higher morbidity in malignant bile duct obstruction than the endoscopic transpapillary approach"'; similar advantages might also be expected using this technique for placement of both the iridium-192 wire and the subsequent endoprosthesis. A (Fig. 2) . The loaded guidewire was heat sterilised in an autoclavable transport container. 13 The upper limit of the malignant stricture was delineated by a nasobiliary cholangiogram and the loaded guidewire was then passed down one limb of a Y-connector (Cook PSFLL-PCF-MLL-30) attached to the proximal end of the nasobiliary catheter. Positioning of the iridium-192 segment across the stricture was facilitated by the greater radiodensity of the iridium-192 wire compared with the outer sheath of the guidewire. The guidewire was fixed proximally within its limb of the Y-connector to prevent dislodgement; external bile drainage was established asobiliary catheter. through the other limb. Prophylactic antibiotics were given routinely. ability of wideTherapy was designed to administer 6000 cGy with and nasobiliary 100% of the dose delivered at a distance of 0-5 cm initial procedure from the iridium-192 wire. Dislodgement of the ter could not be nasobiliary catheter occurred in three patients. In and was inserted one of these, the catheter was repositioned and the -192 therapy and course of intraluminal irradiation completed; in the ried out by this other two no further intraluminal irradiation was attempted (4100 and 4500 cGy delivered). The ered through the duration of therapy was determined by the length and and stents (8- 
